Peer-influenced content. Sources you trust. No registration required. This is HCN.


Cancer Therapy Advisor

Combination Treatment of HER2-Positive Early Breast Cancer with High Recurrence Risk

Oncology, Medical February 5th 2024

Oncology Learning Network

Loco-Regional Irradiation for Patients with Biopsy-Proven Axillary Node Involvement Who Become Node-Negative After Neoadjuvant Chemotherapy

Oncology, Medical January 8th 2024

The New England Journal of Medicine

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

Oncology, Medical November 6th 2023

Cancer Therapy Advisor

T-VEC Demonstrates Long-Term Efficacy in High-Risk Melanoma

Dermatology October 2nd 2023

Renal & Urology News

Intensified Neoadjuvant Therapy Improves Outcomes in Very High-Risk Prostate Cancer

Oncology, Medical September 19th 2023

Cancer Therapy Advisor

Neoadjuvant dd-MVAC Bests Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer

Oncology, Medical June 20th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form